Walleye Trading LLC Otonomy, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.31 $25,556 - $34,931	-15,122 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.2 $83,406 - $150,405	-68,366 Reduced 81.89%	15,122 $29,000
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.67 $129,495 - $167,841	62,862 Added 304.77%	83,488 $186,000
Q1 2021 May 17, 2021	BUY	$2.49 - $6.23 $51,358 - $128,499	20,626 New	20,626 $53,000
Q4 2018 Feb 14, 2019	SELL	$1.51 - $2.93 $38,989 - $75,655	-25,821 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.95 $67,134 - $101,992	25,821 New	25,821 $71,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.